ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 489

Early Detection of Inflammatory Arthritis: The Role of Musculoskeletal Symptoms, Infections and Rheumatoid Arthritis-Related Comorbidities in Primary Care

Marian van Beers-Tas1, Markus Nielen2, Joke C. Korevaar2 and Dirkjan van Schaardenburg3, 1Rheumatology, Amsterdam Rheumatology & Immunology Center, Reade, Amsterdam, Netherlands, 2NIVEL (Netherlands Institute for Health Services Research), Utrecht, Netherlands, 3Rheumatology, Amsterdam Rheumatology and immunology Center, location Academic Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster I: Clinical Characteristics/Presentation/Prognosis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

ACR ABSTRACT 2016   Early detection of inflammatory arthritis: the role of musculoskeletal symptoms, infections and rheumatoid arthritis-related comorbidities in primary care Background/Purpose: Rheumatoid arthritis is characterized by clinically apparent inflammatory arthritis (IA). A preclinical phase has been recognized in which symptoms arise and ambulatory care utilization increases. However, information on location and timing of symptoms before IA diagnosis is still largely lacking. The present study was undertaken to identify pathogenetic clues to the development of IA and to assist early identification of future IA patients with a focus on musculoskeletal symptoms, infections and chronic comorbidities.

Methods: We conducted a nested case-control study using data from electronic medical records of general practitioners, participating in NIVEL Primary Care Database, to evaluate timing and numbers of visits for 192 symptoms and diseases up to nine years before diagnosis of IA. To this end we used the International Classification of Primary Care (ICPC-1) coding system. 2772 patients who received a new diagnosis of IA between 2012 and 2014 were matched (ratio 1:2) with controls on  age, gender, general practice and retrospective duration of follow-up. The frequency of primary care visits between the IA patients and controls were compared using logistic regression in different time periods before diagnosis.

Results: The consultation rate for musculoskeletal symptoms was increased in IA patients in the last 1.5 years before diagnosis with odds ratios (ORs) of 1.8 (confidence interval; CI: 1.6-2.1, p-value<0.05), 1.4 (CI 1.2-1.6, p<0,05) and 1.3 (CI 1.1-1.5, p<0.05), respectively, at 6, 12 and 18 months before diagnosis. For infections, the consultation rate was significantly higher 6 and 18 months prior to diagnosis (OR=1.2; both CI: 1.1-1.4, p-value<0.05). Finally, for IA-related disease and other chronic diseases a significant difference was observed only 3 months before diagnosis with ORs of 1.2 (CI 1.02-1.3, p<0.05) and 1.3 (CI 1.1-1.5, p<0.05) respectively. All ORs are corrected for age and gender. Important contributors to the above mentioned significance levels were presence of shoulder complaints (16.1% in the IA-patients versus 9.6% in the controls; chi2 73.9, p<0.001), hand/finger complaints syndrome (12.2% versus 5.6%; chi2 112.5, p<0.001), carpal tunnel syndrome (5% versus 2.5%; chi2 37.1, p<0.001) and foot/toe complaints (15.2% versus 9.2%; chi2 67.0, p<0.001).

Conclusion: We found significantly increased consultation rates in general practice for musculoskeletal symptoms and infectious diseases prior to the diagnosis of IA. This diverging trend started 4-6 years before diagnosis, but becomes statistically significant around 1.5 years preceding diagnosis. Possibly, these symptoms can be used to develop methods for earlier detection of IA in general practice.

 


Disclosure: M. van Beers-Tas, None; M. Nielen, None; J. C. Korevaar, None; D. van Schaardenburg, None.

To cite this abstract in AMA style:

van Beers-Tas M, Nielen M, Korevaar JC, van Schaardenburg D. Early Detection of Inflammatory Arthritis: The Role of Musculoskeletal Symptoms, Infections and Rheumatoid Arthritis-Related Comorbidities in Primary Care [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/early-detection-of-inflammatory-arthritis-the-role-of-musculoskeletal-symptoms-infections-and-rheumatoid-arthritis-related-comorbidities-in-primary-care/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/early-detection-of-inflammatory-arthritis-the-role-of-musculoskeletal-symptoms-infections-and-rheumatoid-arthritis-related-comorbidities-in-primary-care/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology